Wells Fargo & Company Pulse Biosciences, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 8,362 shares of PLSE stock, worth $121,750. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,362

Previous 7,995 4.59%

Holding current value

$121,750

Previous $69,000 34.78%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$6.69 - $14.54 $2,455 - $5,336	367 Added 4.59%	8,362 $93,000
Q1 2024 May 10, 2024	SELL	$7.8 - $11.02 $41,254 - $58,284	-5,289 Reduced 39.81%	7,995 $69,000
Q4 2023 Feb 09, 2024	SELL	$3.85 - $12.84 $6,256 - $20,865	-1,625 Reduced 10.9%	13,284 $162,000
Q3 2023 Nov 13, 2023	SELL	$4.03 - $8.73 $10,026 - $21,720	-2,488 Reduced 14.3%	14,909 $60,000
Q2 2023 Aug 15, 2023	BUY	$3.67 - $8.64 $31,906 - $75,116	8,694 Added 99.9%	17,397 $125,000
Q1 2023 May 12, 2023	SELL	$2.48 - $3.88 $4,583 - $7,170	-1,848 Reduced 17.51%	8,703 $29,000
Q4 2022 Feb 13, 2023	BUY	$1.73 - $2.89 $3,965 - $6,623	2,292 Added 27.75%	10,551 $29,000
Q3 2022 Nov 14, 2022	SELL	$1.23 - $2.3 $293 - $549	-239 Reduced 2.81%	8,259 $19,000
Q2 2022 Aug 12, 2022	SELL	$1.48 - $4.28 $4,506 - $13,032	-3,045 Reduced 26.38%	8,498 $13,000
Q1 2022 May 16, 2022	SELL	$4.21 - $14.79 $43,741 - $153,668	-10,390 Reduced 47.37%	11,543 $56,000
Q4 2021 Feb 14, 2022	BUY	$14.78 - $24.4 $122,348 - $201,983	8,278 Added 60.62%	21,933 $324,000
Q3 2021 Nov 15, 2021	BUY	$17.25 - $26.63 $56,493 - $87,213	3,275 Added 31.55%	13,655 $295,000
Q2 2021 Aug 16, 2021	SELL	$16.31 - $23.64 $419,199 - $607,595	-25,702 Reduced 71.23%	10,380 $170,000
Q1 2021 May 13, 2021	BUY	$22.43 - $44.27 $249,802 - $493,034	11,137 Added 44.65%	36,082 $855,000
Q4 2020 Feb 09, 2021	SELL	$11.66 - $24.5 $25,547 - $53,679	-2,191 Reduced 8.07%	24,945 $595,000
Q3 2020 Nov 05, 2020	SELL	$9.27 - $13.14 $35,216 - $49,918	-3,799 Reduced 12.28%	27,136 $320,000
Q2 2020 Aug 13, 2020	BUY	$6.23 - $13.09 $81,837 - $171,950	13,136 Added 73.8%	30,935 $324,000
Q1 2020 May 14, 2020	BUY	$5.23 - $15.2 $93,088 - $270,544	17,799 New	17,799 $128,000

Others Institutions Holding PLSE

# of Institutions

Shares Held

4.8M

Call Options Held

138K

Put Options Held

96.2K

View Full List

About Pulse Biosciences, Inc.

Ticker PLSE
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,125,900
Market Cap $541M
Description
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...

More about PLSE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Pulse Biosciences, Inc. Transaction History